PMI Accused of Manipulating Science for Profit: Guardian Report

PMI by 2FIRSTS.ai
Jul.02.2024
PMI Accused of Manipulating Science for Profit: Guardian Report
PMI accused of manipulating science for profit through research funding and advocacy efforts, targeting non-smokers with IQOS products.

According to a recent report by The Guardian, Philip Morris International (PMI) has been accused of "manipulating science for profit" through funding scientific research and advocacy work.

 

Activists say that leaked documents from PMI and its Japanese subsidiary also reveal their plans to target politicians, doctors, and the marketing strategy for the 2020 Tokyo Olympics in order to attract non-smokers to use their heated tobacco product, IQOS.

 

Japan is the initial market for IQOS, with the tobacco industry watchdog organization Stopping Tobacco Organisations and Products (Stop) stating concerns that PMI may apply this strategy to other markets.

 

A research report from the Tobacco Control Research Group at the University of Bath in the UK has revealed that Philip Morris Japan (PMJ) funded a smoking cessation study at Kyoto University through a third-party research institution.

 

Despite a spokesperson for PMI stating that its participation was announced at the 2021 Greek Science Conference, researchers claim that they have been unable to find any public records of PMI's involvement.

 

The PMJ pays approximately £20,000 per month to FTI-Innovations, a life science consulting company managed by a professor from the University of Tokyo, to promote PMI's science and products in academic activities. An internal email from a PMJ employee stated that they were instructed to "keep it confidential.

 

This paper, published in the Journal of Nicotine and Tobacco Research, is based on 24 leaked company documents from the years 2012 to 2020.

 

Researchers say that

 

These activities are similar to known strategies that influence the research, publication, and dissemination of science, while concealing scientific activity.

 

One of the authors of the paper, Dr. Sophie Braznell, stated that

 

The manipulation of science for profit has harmed all of us, especially policymakers and consumers trying to make potentially life-changing decisions. This has hindered and undermined public health policies, while encouraging the widespread use of harmful products.

 

Brazier argued that the leaked documents undermined the PMI's claim of conducting "transparent science" and called for reforms in the funding and governance of tobacco research "to protect science from corporate interests.

 

In a separate report based on leaked documents, Stop claimed that PMJ appeared to be lobbying for permission to use IQOS in smoke-free areas for their company marketing activities.

 

Stop indicates that organizations including medical and hospitality groups, as well as the Japan Fire and Disaster Management Agency, have been targeted as supporters, "if supported, it could give the impression that IQOS is widely accepted."

 

The focus on the Tokyo Olympics reflects a known industry strategy in sports events to promote addictive and harmful tobacco products by associating them with health, misleading consumers, and targeting children and young people. STOP Director Jorge Alday stated that the investigation results contradict PMI's claim that IQOS is only intended for adult smokers.

 

The intention of PMI with IQOS seems to far exceed what they have claimed. This finding adds weight to doubts about PMI's intentions and product statements.

 

Alarming is the implication of a wider deceptive strategy pattern, which may lay the foundation for a new chapter in the tobacco epidemic.

 

A spokesperson for PMI stated that

 

This is yet another false story from an organization that is more focused on criticizing our company rather than helping reduce the harms of smoking. Like any highly regulated multinational company, PMI regularly shares our positions on issues that impact our consumers, company, and communities. This engagement is not only completely legal and appropriate, but also crucial for inclusive policy making that leads to better policy outcomes.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Outlines Manufacturing Requirements as Critical to ENDS PMTA Success
FDA Outlines Manufacturing Requirements as Critical to ENDS PMTA Success
FDA officials said manufacturing consistency is a core prerequisite for ENDS PMTA reviews, not a procedural formality. During its February 10, 2026 roundtable, the agency outlined expectations for quality management systems, manufacturing documentation, nicotine control, stability studies, and risk mitigation, emphasizing that robust manufacturing evidence underpins determinations of whether products are appropriate for the protection of public health.
Feb.11
Thai Research describes e-cigarettes as a “first gateway” for ages 15–20, linked to appearance and flavors
Thai Research describes e-cigarettes as a “first gateway” for ages 15–20, linked to appearance and flavors
A Thai report says Minister attached to the Prime Minister’s Office Santi Piyatat is advancing efforts toward a vape-free society. On Jan. 12, a seminar at the Thai Health Promotion Foundation’s learning center presented a study covering six regions of Thailand on spending related to cigarettes and e-cigarettes and the behavior of different smoker groups.
Jan.13 by 2FIRSTS.ai
Metal Body + AMOLED Screen: KT&G Launches New Heated Tobacco Device Lil Aible 3.0
Metal Body + AMOLED Screen: KT&G Launches New Heated Tobacco Device Lil Aible 3.0
KT&G said it will launch the heated tobacco device Lil Aible 3.0 at four stores in South Korea on February 28. The device shortens charging and preheating time while keeping features such as pausing during use, mode switching, and three consecutive uses. It adopts a metal body and an AMOLED display, comes in four colors, and will expand to Seoul-area convenience stores and the online mall in April, and nationwide convenience stores in May.
Feb.27 by 2FIRSTS.ai
Isle of Wight councillors raise concerns about youth vaping; one says it may be seen “akin to asbestos”
Isle of Wight councillors raise concerns about youth vaping; one says it may be seen “akin to asbestos”
Concerns about the effects of vaping on young people and public health were raised at County Hall, the report said, with Cllr Chris Jarman saying it may one day be viewed as “akin to asbestos.” Jarman cited NHS-related research and a case highlighted by Hull University Teaching Hospitals NHS Trust: a 15-year-old admitted with chest pain and breathing difficulty who reported cannabis use and vaping about 500 puffs per day and was diagnosed via CT with “air leak syndrome.”
Feb.27 by 2FIRSTS.ai
PMI’s Portuguese unit to launch nicotine pouches in 2026 after tax clarification
PMI’s Portuguese unit to launch nicotine pouches in 2026 after tax clarification
After Portugal included nicotine pouches in the excise-tax (IEC) framework for tobacco and nicotine products, PMI’s Portuguese subsidiary Tabaqueira confirmed it will begin selling nicotine pouches in the country this year. The company is preparing a soft launch in two stores ahead of wider distribution, as the tax and regulatory position becomes clearer.
Mar.10 by 2FIRSTS.ai
Special Report | Belarus Rejects Vape Ban, Opts for Tighter Market Controls
Special Report | Belarus Rejects Vape Ban, Opts for Tighter Market Controls
After weeks of debate over a potential blanket prohibition, Belarus has decided against banning electronic cigarettes, choosing instead to tighten control over wholesale, imports and licensing. President Alexander Lukashenko warned that an outright ban could drive the market underground and undermine state revenues, as officials move to curb widespread illicit trade while keeping retail sales largely intact.
Mar.04